U078 Vitiligo: Evidenced Based Medicine Applied to Cases
DESCRIPTION
We will review key topics in vitiligo from international experts. Pediatrics, phototherapy combined with JAKi, skin cancer risk in vitiligo will be reviewed.
LEARNING OBJECTIVES
Summarize the new data available that dispels myths about treating vitiligo, so patients receive the best possible treatment
Discuss what is still unknown regarding vitiligo treatment and how to communicate with patients the information important to them for compassionate care
SCHEDULE
4:30 PM
Introduction
David Rosmarin, MD, FAAD
4:35 PM
Skin Cancer and Vitiligo
Khaled Ezzedine, MD, PhD, IFAAD
4:47 PM
Vitiligo in Pediatric Patients
Viktoria Eleftheriadou, MD, PhD
4:59 PM
Evidence to add UV-lights in combination with topical or systemic treatments
Julien Seneschal, MD, PhD
5:13 PM
Comorbidities
Nanette Blythe Silverberg, MD, FAAD
DIRECTOR
David Rosmarin, MD, FAAD
SPEAKERS
Viktoria Eleftheriadou, MD, PhD
Khaled Ezzedine, MD, PhD, IFAAD
Julien Seneschal, MD, PhD
Nanette Blythe Silverberg, MD, FAAD
DISCLOSURES
Viktoria Eleftheriadou, MD, PhD
No financial relationships exist with ineligible companies.
Khaled Ezzedine, MD, PhD, IFAAD
AbbVie – Advisory Board(Fees); BMS – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
David Rosmarin, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Abcuro, Inc. – Consultant(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); AltruBio Inc. – Consultant(Honoraria); Amgen – Speaker(Honoraria); Arena Pharmaceuticals – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Celgene Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Concert Pharmaceuticals – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); CSL Behring – Consultant(Honoraria); Dermavant Sciences – Advisory Board(Honoraria), Speaker(Honoraria); Dermira – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding), Other(Other Financial Benefit), Speaker(Honoraria); Janssen Biotech – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Merck & Co., Inc – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); RAPT Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Recludix Pharma – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Revolo Therapeutics – Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); UCB – Advisory Board(Honoraria); Viela Bio – Advisory Board(Honoraria); Zura Bio – Consultant (1099 relationship)(Honoraria);
Julien Seneschal, MD, PhD
No financial relationships exist with ineligible companies.
Nanette Blythe Silverberg, MD, FAAD
Incyte Corporation – Consultant(Grants/Research Funding); Pelthos Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); regeneron – Speaker(Honoraria);